Research Paper Volume 14, Issue 13 pp 5571—5589
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
Figure 11. Characteristics of immune microenvironment and immunotherapy sensitivity in two risk factor groups. (A) The heatmap of immune responses. (B) The scores of immune cells and (C) immune-related functions in high and low risk groups. (D) The expression of immune checkpoints among high and low risk groups. (E) Kaplan-Meier survival curve of GSE135222 cohort for PFS. (F) ROC analysis in the GSE135222. (G) Compared the score of TIDE between high and low risk groups. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant.